共 79 条
- [1] Collins A(2020)Addressing co-occurring public health emergencies: the importance of naloxone distribution in the era of COVID-19 Int J Drug Policy 83 102872-302
- [2] Ndoye C(2020)COVID-19 has “devastating” effect on women and girls Lancet 396 301-337
- [3] Arene-Morley D(2019)Supervised injection facility utilization patterns: a prospective cohort study in Vancouver, Canada Am J Prev Med 57 330-e7
- [4] Marshall B(2020)Opioid use disorder and COVID-19: crashing of the crises J Addict Med 14 e6-749
- [5] Cousins S(2021)Supervised injection facilities as harm reduction: a systematic review Am J Prev Med 61 738-1437
- [6] Kennedy M(2020)Sourcing personal protective equipment during the COVID-19 pandemic JAMA 323 1912-366
- [7] Klassen D(2011)Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study Lancet 377 1429-584
- [8] Dong H(2019)Willingness to use safe consumption spaces among opioid users at high risk of fentanyl overdose in Baltimore, Providence, and Boston J Urban Health 96 353-68
- [9] Milloy M(2018)Opening Canada’s first Health Canada-approved supervised consumption sites Can J Public Health 109 581-90
- [10] Hayashi K(2014)Supervised injection services: what has been demonstrated? A systematic literature review Drug Alcohol Depend 145 48-e289